Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 3,622,300 | 2,909,800 | 2,448,500 | 1,926,700 | 1,476,000 |
| Cost of Goods | 1,333,400 | 1,026,700 | 768,000 | 646,600 | 544,500 |
| Gross Profit | 2,288,900 | 1,883,100 | 1,680,500 | 1,280,100 | 931,500 |
| Operating Expenses | 1,691,600 | 1,492,600 | 1,414,700 | 981,200 | 789,700 |
| Operating Income | 597,700 | 391,200 | 265,800 | 299,500 | 142,300 |
| Interest Expense | 0 | 0 | 0 | 17,700 | 60,300 |
| Other Income | 112,700 | -400 | -9,000 | 16,100 | 22,200 |
| Pre-tax Income | 710,400 | 390,800 | 256,800 | 297,900 | 104,200 |
| Income Tax | 168,900 | 49,600 | 39,900 | -251,800 | 3,100 |
| Net Income Continuous | 541,500 | 341,200 | 216,900 | 549,700 | 101,100 |
| Net Income | $541,500 | $341,200 | $216,900 | $549,700 | $101,100 |
| EPS Basic Total Ops | 1.40 | 0.88 | 0.56 | 1.46 | 0.28 |
| EPS Basic Continuous Ops | 1.40 | 0.88 | 0.56 | 1.46 | 0.28 |
| EPS Diluted Total Ops | 1.30 | 0.82 | 0.53 | 1.33 | 0.28 |
| EPS Diluted Continuous Ops | 1.27 | 0.80 | 0.51 | 1.31 | 0.27 |
| EPS Diluted Before Non-Recurring Items | 1.52 | 0.87 | 0.67 | 0.78 | 0.46 |
| EBITDA(a) | $783,700 | $547,100 | $367,800 | $366,600 | $191,000 |